Clinical Trial Update: Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar Extraction [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating etanercept (Enbrel) for pain and swelling after third molar extraction in healthy volunteers with inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) | Conditions: Healthy, Inflammation | Phase 2 | Status: COMPLETED